Most of these applications showed effectiveness against skin-associated diseases, such as ItP of IL-10 for atopic dermatitis, STAT3 siRNA for skin cancer, and TNF-α drug etanercept for psoriasis. This evidence concerns the gene IL10 and atopic eczema.